Long-Term Antibody Response to SARS-CoV-2 in Children

M. Aepfelbacher | S. Blankenberg | Madalena Barroso | M. Addo | P. Arck | K. Hecher | D. Lessel | G. Escherich | E. Vettorazzi | S. Rutkowski | C. Drosten | S. Etzold | R. Kobbe | M. Kemper | S. Gersting | C. Kemen | P. Deindl | J. Schmiesing | J. Oh | F. Arndt | R. Kozlik-Feldmann | J. Schulze zur Wiesch | J. Olfe | Marianne Klokow | Michael Boettcher | K. Reinshagen | Philippe Stock | M. Danecka | A. Muntau | I. Müller | J. Schrum | A. Diemert | V. Stark | P. Höger | K. Hermann | A. Kruchen | D. Singer | K. Paul | M. Woidy | Friederike S. Neumann | M. Blohm | G. Engels | Cornelius Rau | Daniel Tegtmeyer | I. Goebel | G. Dunay | I. Schäfer | Peer Hauck | T. Kehl | G. Müller | D. Zazara | K. Wenke | C. Schmitt | Anja Grosse Lordemann | M. Krumm | L. Haupt | S. Tiede | A. Zapf | Caroline Stiel | Armin Hoffmann | F. Sibbertsen | L. Hecher | A. Kohl | T. Mir | Pelin Kurnaz | L. Grinstein | F. Schlenker | Theresa Harbauer | M. Bergers | M. Luetgehetmann | J. Knobloch | D. Noerz | B. Hartz | J. Beime | K. Fehse | F. Haniel | T. Klokow | Stefanie Ingrid Armin Pia-Sophie Lea Markus Pia Barbara Ann Etzold Goebel Günther Kantor Bandel Baum | Armin Günther | Pia-Sophie Kantor | Lea Bandel | Markus Baumanns | Pia Dähler | Barbara Dwenger | Annika-Linnea Erdmann | Sophia Hegselmann | K. Hornig | Johanna Jipp | P. Kirkerup | Sabine Pasterkamp | Anna Serve | Julia Terstegen | Ceri Theresa Wiedling | Madelaine Wingerath | B. Winkler | Daniel Diaz | P. Wiegand | Kathrin Cermann | Corinna Cramer | Maria-Dorothee Neumann | Joana Adler Fernandes de Abreu | Julia Strauss | Jens-Owe Vogel | Maximilian Noelle-Wying | J. Strauss | Pia Kirkerup | Friederike Neumann

[1]  Jie Zhou,et al.  The SARS-CoV-2 variant, Omicron, shows rapid replication in human primary nasal epithelial cultures and efficiently uses the endosomal route of entry , 2022 .

[2]  L. Poon,et al.  SARS-CoV-2 Omicron variant replication in human respiratory tract ex vivo , 2021 .

[3]  John Wright,et al.  Children develop robust and sustained cross-reactive spike-specific immune responses to SARS-CoV-2 infection , 2021, Nature immunology.

[4]  S. Hoehl,et al.  Reduced Neutralization of SARS-CoV-2 Omicron Variant by Vaccine Sera and monoclonal antibodies , 2021, medRxiv.

[5]  M. Bracho,et al.  RNA viral loads of SARS-CoV-2 Alpha and Delta variants in nasopharyngeal specimens at diagnosis stratified by age, clinical presentation and vaccination status , 2021, Journal of Infection.

[6]  H. Whitaker,et al.  Large increases in SARS-CoV-2 seropositivity in children in England: Effects of the delta wave and vaccination , 2021, Journal of Infection.

[7]  M. Rämet,et al.  Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age , 2021, The New England journal of medicine.

[8]  N. Ferguson,et al.  Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study , 2021, The Lancet Infectious Diseases.

[9]  Hongbing Shen,et al.  Kinetics of SARS-CoV-2 Specific and Neutralizing Antibodies over Seven Months after Symptom Onset in COVID-19 Patients , 2021, Microbiology spectrum.

[10]  S. Bhatt,et al.  SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion , 2021, Nature.

[11]  M. Whelan,et al.  Association of Age and Pediatric Household Transmission of SARS-CoV-2 Infection. , 2021, JAMA pediatrics.

[12]  J. Karakaya,et al.  Longitudinal Follow-up of Antibody Responses in Pediatric Patients With COVID-19 up to 9 Months After Infection , 2021, The Pediatric infectious disease journal.

[13]  G. Biele,et al.  Estimating infectiousness throughout SARS-CoV-2 infection course , 2021, Science.

[14]  E. Anis,et al.  Nationwide seroprevalence of antibodies against SARS-CoV-2 in Israel , 2021, European Journal of Epidemiology.

[15]  Weizhong Yang,et al.  Seroprevalence and humoral immune durability of anti-SARS-CoV-2 antibodies in Wuhan, China: a longitudinal, population-level, cross-sectional study , 2021, The Lancet.

[16]  P. Soler-Palacín,et al.  Household SARS-CoV-2 transmission and children: a network prospective study , 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  Y. Choe,et al.  Geospatial Analysis of Age-specific SARS-CoV-2 Transmission Patterns in Households, Korea , 2021, Journal of Korean medical science.

[18]  Bjoern Peters,et al.  Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection , 2021, Science.

[19]  K. Nygård,et al.  Minimal transmission of SARS-CoV-2 from paediatric COVID-19 cases in primary schools, Norway, August to November 2020 , 2021, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[20]  M. Halloran,et al.  Household Transmission of SARS-CoV-2 , 2020, JAMA network open.

[21]  S. Ladhani,et al.  Kinetics and seroprevalence of SARS-CoV-2 antibodies in children , 2020, The Lancet Infectious Diseases.

[22]  E. Hod,et al.  Distinct antibody responses to SARS-CoV-2 in children and adults across the COVID-19 clinical spectrum , 2020, Nature Immunology.

[23]  C. Reed,et al.  Transmission of SARS-COV-2 Infections in Households — Tennessee and Wisconsin, April–September 2020 , 2020, MMWR. Morbidity and mortality weekly report.

[24]  Wenling Wang,et al.  Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial , 2020, The Lancet Infectious Diseases.

[25]  J. Salomon,et al.  The household secondary attack rate of SARS-CoV-2: A rapid review. , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[26]  R. Viner,et al.  Susceptibility to SARS-CoV-2 Infection Among Children and Adolescents Compared With Adults: A Systematic Review and Meta-analysis. , 2020, JAMA pediatrics.

[27]  B. Horta,et al.  SARS-CoV-2 antibody prevalence in Brazil: results from two successive nationwide serological household surveys , 2020, The Lancet Global Health.

[28]  Scott J. Garforth,et al.  Immune responses to SARS-CoV-2 infection in hospitalized pediatric and adult patients , 2020, Science Translational Medicine.

[29]  Joseph M. Campos,et al.  Kinetics of Viral Clearance and Antibody Production Across Age Groups in Children with Severe Acute Respiratory Syndrome Coronavirus 2 Infection , 2020, The Journal of Pediatrics.

[30]  G. Kochs,et al.  Prevalence of SARS-CoV-2 Infection in Children and Their Parents in Southwest Germany , 2020, JAMA pediatrics.

[31]  E. Walsh,et al.  Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults , 2020, Nature.

[32]  E. Wald,et al.  A Pediatric Infectious Disease Perspective on COVID-19 , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[33]  S. Yerly,et al.  Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Viral Load in the Upper Respiratory Tract of Children and Adults With Early Acute Coronavirus Disease 2019 (COVID-19) , 2020, Clinical Infectious Diseases.

[34]  J. Mascola,et al.  SARS-CoV-2 mRNA Vaccine Design Enabled by Prototype Pathogen Preparedness , 2020, Nature.

[35]  M. Halloran,et al.  Household transmission of SARS-CoV-2: a systematic review and meta-analysis of secondary attack rate , 2020, medRxiv.

[36]  U. Reimer,et al.  SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19 , 2020, Nature.

[37]  J. Merckx,et al.  Transmission of SARS-CoV-2 by Children. , 2020, Deutsches Arzteblatt international.

[38]  C. Mohan,et al.  Epidemiology and transmission dynamics of COVID-19 in two Indian states , 2020, Science.

[39]  A. Sette,et al.  Pre-existing immunity to SARS-CoV-2: the knowns and unknowns , 2020, Nature Reviews Immunology.

[40]  K. Ng,et al.  Household Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 from Adults to Children , 2020, The Journal of Pediatrics.

[41]  M. Hernán,et al.  Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study , 2020, The Lancet.

[42]  C. Murray,et al.  COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study , 2020, The Lancet Child & Adolescent Health.

[43]  E. Conway,et al.  Multisystem Inflammatory Syndrome in Children Associated with Severe Acute Respiratory Syndrome Coronavirus 2 Infection (MIS-C): A Multi-institutional Study from New York City , 2020, The Journal of Pediatrics.

[44]  A. Flahault,et al.  Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study , 2020, The Lancet.

[45]  G. Gao,et al.  Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2 , 2020, Cell.

[46]  David C. Yeo,et al.  Brief clinical evaluation of six high-throughput SARS-CoV-2 IgG antibody assays , 2020, Journal of Clinical Virology.

[47]  Q. Hamid,et al.  Airways Expression of SARS-CoV-2 Receptor, ACE2, and TMPRSS2 Is Lower in Children Than Adults and Increases with Smoking and COPD , 2020, Molecular Therapy - Methods & Clinical Development.

[48]  Chinese Center for Disease Control and Prevention,et al.  Technical Guidelines for COVID-19 Laboratory Testing , 2020, China CDC weekly.

[49]  G. Ippolito,et al.  The immune system of children: the key to understanding SARS-CoV-2 susceptibility? , 2020, The Lancet Child & Adolescent Health.

[50]  P. Theocharis,et al.  Hyperinflammatory shock in children during COVID-19 pandemic , 2020, The Lancet.

[51]  David S. Fischer,et al.  Integrated analyses of single-cell atlases reveal age, gender, and smoking status associations with cell type-specific expression of mediators of SARS-CoV-2 viral entry and highlights inflammatory programs in putative target cells , 2020, bioRxiv.

[52]  A. Tagarro,et al.  Screening and Severity of Coronavirus Disease 2019 (COVID-19) in Children in Madrid, Spain. , 2020, JAMA pediatrics.

[53]  Zhongyi Jiang,et al.  Epidemiology of COVID-19 Among Children in China , 2020, Pediatrics.

[54]  Susanne Pfefferle,et al.  Evaluation of a quantitative RT-PCR assay for the detection of the emerging coronavirus SARS-CoV-2 using a high throughput system , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[55]  J. Xiang,et al.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study , 2020, The Lancet.

[56]  Victor M Corman,et al.  Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[57]  Shinhao Yang,et al.  The size and concentration of droplets generated by coughing in human subjects. , 2007, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.

[58]  Interim Guidelines for COVID-19 Antibody Testing in Clinical and Public Health Settings , 2020 .